Compounds > 3-iodobenzylguanidine
Page last updated: 2024-08-24

3-iodobenzylguanidine and Parkinsonian Disorders

3-iodobenzylguanidine has been researched along with Parkinsonian Disorders in 38 studies

Research

Studies (38)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (28.95)29.6817
2010's25 (65.79)24.3611
2020's2 (5.26)2.80

Authors

AuthorsStudies
Ikeda, T; Ikenoshita, S; Masuda, T; Nakahara, K; Sakamoto, F; Shiraishi, S; Yamashita, S1
Hashimoto, M; Ito, D; Iwabuchi, Y; Jinzaki, M; Kameyama, M; Matsusaka, Y; Narimatsu, H; Seki, M; Tabuchi, H; Yamada, Y1
Eriguchi, M; Fujioka, S; Hara, H; Hattori, N; Houzen, H; Li, Y; Mishima, T; Nishioka, K; Sato, K; Shiomi, K; Tsuboi, Y; Yabe, I1
Harada, M; Izumi, Y; Kaji, R; Kunikane, Y; Otomi, Y; Otsuka, H; Sako, W; Shinya, T; Takashi, S; Uyama, N; Watanabe, Y1
Hikichi, C; Hirota, S; Ishikawa, T; Ito, S; Maeda, T; Mizutani, Y; Murate, K; Mutoh, T; Nagao, R; Niimi, Y; Shima, S; Ueda, A1
Galleri, G; Madeddu, G; Mulas, A; Nieddu, A; Nuvoli, S; Piras, MR; Rocchitta, G; Serra, PA; Spanu, A1
Huo, L; Li, F; Wang, H; Xu, D; Zhu, S; Zhu, W1
Kim, JS; Lee, JE; Lee, KS; Oh, YS; Ryu, DW; Yoo, IR; Yoo, SW1
Iwabuchi, Y; Jinzaki, M; Matsusaka, Y; Minami, Y; Nakahara, T1
Agostini, D; Defer, GL; Lamotte, G; Lebasnier, A; Morello, R1
Cameron, A; Hayhow, B; Middlemost, M1
Denis, A; Guillaume, L1
Asakura, K; Fukui, T; Hikichi, C; Hirota, S; Ishikawa, T; Ito, S; Kizawa, M; Mizutani, Y; Murate, K; Mutoh, T; Shima, S; Ueda, A1
Hattori, N; Li, Y; Takanashi, M1
Fujishiro, H; Kosaka, K; Ozaki, N; Ukai, K; Watanabe, M1
Fujita, H; Hirata, K; Miyamoto, M; Miyamoto, T; Numao, A; Suzuki, K; Uchiyama, T; Watanabe, Y1
Hasegawa, K; Kowa, H; Stoessl, AJ; Wszolek, ZK; Yagishita, S; Yokoyama, T1
Arai, K; Asahina, M; Funayama, M; Hattori, N; Hattori, T; Kanai, K; Kuwabara, S; Kuwabara, Y; Sekiguchi, Y; Tomiyama, H; Uchiyama, T1
Chung, EJ; Kim, BJ; Lee, GH; Lee, WY; Yoon, WT1
Rascol, O; Schelosky, L1
Diederich, NJ; Fröhlich, I; Pilloy, W; Vaillant, M1
Buongiorno, M; De la Cerda, A; Ezquerra, M; Gaig, C; Lomeña, F; Martí, MJ; Muxí, A; Navales, I; Paredes, P; Santacruz, P; Tolosa, E; Valldeoriola, F1
Behnke, S; Dillmann, U; Dorschner, J; Farmakis, G; Fassbender, K; Hellwig, D; Kirsch, CM; Schneider, S; Spiegel, J1
Antke, C; Beu, M; Müller, HW; Nikolaus, S; Schnitzler, A; Südmeyer, M; Wojtecki, L; Zizek, T1
Kondo, C; Kusakabe, K; Momose, M; Uchiyama, S; Uchiyama, Y1
Cason, E; Cocciolillo, F; Di Giuda, D; Fagioli, G; Giordano, A; Stefanelli, A; Treglia, G1
Kokubo, Y; Kuzuhara, S; Morimoto, S; Nomura, Y1
Berganzo, K; Gómez-Esteban, JC; Iodice, V; Lezcano, E; Llorens, V; Low, D; Mathias, CJ; Sánchez-Manso, JC; Somme, JH; Tijero, B; Vichayanrat, E; Zarranz, JJ1
Inoue, M; Inoue, Y; Kishimoto, T; Kiuchi, K; Kosaka, J; Morikawa, M; Norimoto, K1
Abe, K; Deguchi, K; Deguchi, S; Ikeda, Y; Kametaka, S; Kurata, T; Manabe, Y; Morimoto, N; Ohta, T; Ohta, Y; Sato, S; Takao, Y1
Ito, M; Iwasaki, Y; Mimuro, M; Mori, K; Yoshida, M1
Hattori, H; Nakade, S; Orimo, S; Ozawa, E; Takahashi, A; Taki, K; Tsuchiya, K1
Abo, M; Fukumitsu, N; Hattori, N; Honda, H; Inoue, K; Kono, Y; Kurita, A; Orimo, S; Sengoku, R; Suzuki, M1
Fukuda, T; Fukumitsu, N; Kajiyama, S; Kiyono, Y; Saji, H; Suzuki, M1
Choi, YY; Chung, YA; Kim, HT; Kim, J; Kim, JS; Kim, SH; Kim, YI; Lee, KS; Lee, PH; Park, JW1
Annesi, F; Annesi, G; Bagnato, A; Candiano, IC; Civitelli, D; Condino, F; D'Amelio, M; Loizzo, P; Morelli, M; Morgante, L; Nicoletti, G; Novellino, F; Petrone, A; Quattrone, A; Rocca, FE; Savettieri, G; Tarantino, P; Zappia, M1
Braune, S1
Fujiwara, H; Maekawa, N; Saito, K; Takatsu, H; Takemura, M; Wada, H1

Reviews

3 review(s) available for 3-iodobenzylguanidine and Parkinsonian Disorders

ArticleYear
123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Volume: 24 Suppl 2

    Topics: 3-Iodobenzylguanidine; Autonomic Nervous System Diseases; Heart; Humans; Lewy Body Disease; Parkinson Disease; Parkinsonian Disorders; Radionuclide Imaging; Radiopharmaceuticals

2009
MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis.
    Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2012, Volume: 22, Issue:1

    Topics: 3-Iodobenzylguanidine; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Heart; Humans; Lewy Body Disease; Parkinson Disease; Parkinsonian Disorders; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; ROC Curve

2012
The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes.
    Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2001, Volume: 11, Issue:6

    Topics: 3-Iodobenzylguanidine; Animals; Diagnosis, Differential; Humans; Multiple System Atrophy; Myocardium; Neurodegenerative Diseases; Parkinsonian Disorders; Radiopharmaceuticals

2001

Trials

3 trial(s) available for 3-iodobenzylguanidine and Parkinsonian Disorders

ArticleYear
Initial Versus Follow-up Sequential Myocardial 123I-MIBG Scintigraphy to Discriminate Parkinson Disease From Atypical Parkinsonian Syndromes.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:4

    Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Male; Myocardial Perfusion Imaging; Parkinson Disease; Parkinsonian Disorders; ROC Curve

2019
MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Aug-15, Volume: 24, Issue:11

    Topics: 3-Iodobenzylguanidine; Adenosine; Aged; Autonomic Nervous System Diseases; Diagnosis, Differential; Female; Galvanic Skin Response; Heart; Heart Rate; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Respiration; Sensitivity and Specificity; Sympathetic Fibers, Postganglionic; Tomography, Emission-Computed, Single-Photon; Valsalva Maneuver

2009
Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism: a multidimensional statistical approach.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:5

    Topics: 3-Iodobenzylguanidine; Adult; Aged; Algorithms; Benzamides; Diagnosis, Differential; Humans; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Pyrrolidines; Radionuclide Imaging; ROC Curve; Sensitivity and Specificity; Tropanes

2011

Other Studies

32 other study(ies) available for 3-iodobenzylguanidine and Parkinsonian Disorders

ArticleYear
Is 123I-MIBG Scintigraphy Beneficial or Excessive for the Diagnosis of Parkinson's Disease in the Early Phase?
    Neuro-degenerative diseases, 2019, Volume: 19, Issue:2

    Topics: 3-Iodobenzylguanidine; Aged; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Radionuclide Imaging; Retrospective Studies

2019
A diagnostic strategy for Parkinsonian syndromes using quantitative indices of DAT SPECT and MIBG scintigraphy: an investigation using the classification and regression tree analysis.
    European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:6

    Topics: 3-Iodobenzylguanidine; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Humans; Lewy Body Disease; Parkinsonian Disorders; Radionuclide Imaging; Retrospective Studies; Tomography, Emission-Computed, Single-Photon

2021
Meta-iodobenzylguanidine myocardial scintigraphy in Perry disease.
    Parkinsonism & related disorders, 2021, Volume: 83

    Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Biomarkers; Depression; Dynactin Complex; Female; Humans; Hypoventilation; Japan; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinsonian Disorders; Pedigree; Radiopharmaceuticals

2021
The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.
    Nuclear medicine communications, 2017, Volume: 38, Issue:6

    Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Parkinsonian Disorders; ROC Curve; Tomography, Emission-Computed, Single-Photon; Tropanes

2017
Usefulness of combining
    Journal of the neurological sciences, 2017, Jun-15, Volume: 377

    Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinsonian Disorders; Protein Binding; Retrospective Studies; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Tropanes

2017
123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.
    Medicine, 2017, Volume: 96, Issue:21

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Brain; Diagnosis, Differential; Female; Heart; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Nortropanes; Parkinsonian Disorders; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon

2017
Validation of Iodine-131-meta-iodobenzylguanidine cardiac scintigraphy in Parkinsonism: A preliminary study.
    Parkinsonism & related disorders, 2018, Volume: 50

    Topics: 3-Iodobenzylguanidine; Adult; Aged; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Parkinsonian Disorders; Radiopharmaceuticals; Sensitivity and Specificity

2018
Focal 123I-MIBG Uptake in the Medial Segment of the Normal Liver.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:3

    Topics: 3-Iodobenzylguanidine; Aged, 80 and over; Biological Transport; Humans; Incidental Findings; Liver; Male; Parkinsonian Disorders; Single Photon Emission Computed Tomography Computed Tomography

2019
Accuracy and cutoff values of delayed heart to mediastinum ratio with (123)I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses.
    BMC neurology, 2015, May-15, Volume: 15

    Topics: 3-Iodobenzylguanidine; Aged; Brain; Female; Heart; Humans; Lewy Body Disease; Male; Mediastinum; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon

2015
Cardiac (123)I-meta-iodo-benzyl-guanine in a patient with bipolar affective disorder, musical hallucinations and Parkinsonism.
    The Australian and New Zealand journal of psychiatry, 2016, Volume: 50, Issue:1

    Topics: 3-Iodobenzylguanidine; Atrophy; Bipolar Disorder; Brain; Female; Hallucinations; Heart; Humans; Middle Aged; Music; Parkinson Disease; Parkinsonian Disorders; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed

2016
Cardiac
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:1

    Topics: 3-Iodobenzylguanidine; Brain; Heart; Humans; Parkinsonian Disorders; Radionuclide Imaging; Radiopharmaceuticals

2017
Retrospective analysis of parkinsonian patients exhibiting normal (123)I-MIBG cardiac uptake.
    Journal of the neurological sciences, 2015, Dec-15, Volume: 359, Issue:1-2

    Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Enzyme Inhibitors; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Parkinsonian Disorders; Radionuclide Imaging; Retrospective Studies; ROC Curve; Severity of Illness Index

2015
Absence of Lewy pathology associated with PINK1 homozygous mutation.
    Neurology, 2016, 06-07, Volume: 86, Issue:23

    Topics: 3-Iodobenzylguanidine; Brain; Female; Humans; Lewy Bodies; Magnetic Resonance Imaging; Middle Aged; Mutation; Myocardial Perfusion Imaging; Parkinsonian Disorders; Protein Kinases; Radiopharmaceuticals

2016
Similarity of symptoms between transient epileptic amnesia and Lewy body disease.
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2017, Volume: 17, Issue:2

    Topics: 3-Iodobenzylguanidine; Aged; Amnesia; Anticonvulsants; Cognition Disorders; Electroencephalography; Female; Hallucinations; Humans; Levetiracetam; Lewy Body Disease; Myocardial Perfusion Imaging; Parkinsonian Disorders; Piracetam; Seizures; Tomography, Emission-Computed, Single-Photon

2017
Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
    PloS one, 2016, Volume: 11, Issue:11

    Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Heart; Humans; Male; Olfactory Perception; Parkinson Disease; Parkinsonian Disorders; Radionuclide Imaging; Substantia Nigra; Ultrasonography, Doppler, Transcranial

2016
Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes.
    Parkinsonism & related disorders, 2009, Volume: 15, Issue:4

    Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; DNA Mutational Analysis; Family Health; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Isoleucine; Japan; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Parkinsonian Disorders; Positron-Emission Tomography; Protein Serine-Threonine Kinases; Radiopharmaceuticals; Tetrabenazine; Tyrosine

2009
Preserved cardiac (123)I-MIBG uptake and lack of severe autonomic dysfunction in a PARK9 patient.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Jul-15, Volume: 24, Issue:9

    Topics: 3-Iodobenzylguanidine; Adult; Autonomic Nervous System Diseases; Heart; Humans; Leucine; Male; Myocardium; Parkinsonian Disorders; Phenylalanine; Proton-Translocating ATPases; Radionuclide Imaging; Young Adult

2009
Myocardial MIBG scintigraphy: a useful clinical tool? : A retrospective study in 50 parkinsonian patients.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2010, Volume: 31, Issue:3

    Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Aging; Antihypertensive Agents; Diagnosis, Differential; Female; Heart; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinsonian Disorders; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sex Characteristics

2010
123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations.
    Journal of neurology, 2011, Volume: 258, Issue:6

    Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Female; Glycine; Heart; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Polymorphism, Single Nucleotide; Protein Serine-Threonine Kinases; Radionuclide Imaging; Radiopharmaceuticals; Serine; Severity of Illness Index; Smell; Statistics, Nonparametric

2011
Myocardial MIBG scintigraphy may predict the course of motor symptoms in Parkinson's disease.
    Parkinsonism & related disorders, 2011, Volume: 17, Issue:5

    Topics: 3-Iodobenzylguanidine; Adult; Aged; Female; Heart; Humans; Longitudinal Studies; Male; Middle Aged; Motor Activity; Myocardial Perfusion Imaging; Parkinsonian Disorders; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Statistics, Nonparametric

2011
Comparison of parameters of (123)I-metaiodobenzylguanidine scintigraphy for differential diagnosis in patients with parkinsonism: correlation with clinical features.
    Annals of nuclear medicine, 2011, Volume: 25, Issue:7

    Topics: 3-Iodobenzylguanidine; Aged; Analysis of Variance; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Mediastinum; Myocardium; Parkinsonian Disorders; Radionuclide Imaging; Retrospective Studies; ROC Curve; Sensitivity and Specificity

2011
Cardiac ¹²³I-meta-iodobenzylguanidine scintigraphy in patients with amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Kii peninsula, Japan.
    Parkinsonism & related disorders, 2012, Volume: 18, Issue:3

    Topics: 3-Iodobenzylguanidine; Aged; Amyotrophic Lateral Sclerosis; Dementia; Female; Humans; Iodine Radioisotopes; Japan; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinsonian Disorders; Radiopharmaceuticals

2012
SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy.
    Parkinsonism & related disorders, 2012, Volume: 18, Issue:1

    Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Heart; Humans; Male; Mediastinum; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Severity of Illness Index; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon

2012
Parkinsonism with multiple cysts in the bilateral striata.
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2011, Volume: 11, Issue:3

    Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Antipsychotic Agents; Brain Ischemia; Delirium; Delusions; Diagnosis, Differential; Dibenzothiazepines; Dominance, Cerebral; Drug Therapy, Combination; Encephalomalacia; Hallucinations; Humans; Levodopa; Magnetic Resonance Imaging; Male; Neostriatum; Neurologic Examination; Organophosphate Poisoning; Parkinsonian Disorders; Psychoses, Substance-Induced; Quetiapine Fumarate; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2011
PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
    Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:22

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Basal Ganglia; Cerebral Cortex; Cerebrovascular Circulation; Cysteine; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Organotechnetium Compounds; Parkinson Disease; Parkinsonian Disorders; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon

2011
[Decreased myocardial uptake of meta-iodobenzylguanidine in an autopsy-confirmed case of corticobasal degeneration with Lewy bodies restricted to the sympathetic ganglia].
    Rinsho shinkeigaku = Clinical neurology, 2012, Volume: 52, Issue:6

    Topics: 3-Iodobenzylguanidine; Aged; Autopsy; Basal Ganglia; Cerebral Cortex; Diagnosis, Differential; Ganglia, Sympathetic; Heart; Humans; Lewy Bodies; Male; Myocardium; Nerve Degeneration; Nerve Endings; Parkinsonian Disorders; Radionuclide Imaging; Radiopharmaceuticals

2012
[123I] meta-iodobenzylguanidine myocardial scintigraphy differentiates corticobasal degeneration from Parkinson's disease.
    Internal medicine (Tokyo, Japan), 2003, Volume: 42, Issue:1

    Topics: 3-Iodobenzylguanidine; Aged; Basal Ganglia; Cerebral Cortex; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neurodegenerative Diseases; Parkinson Disease; Parkinsonian Disorders; Radionuclide Imaging; Radiopharmaceuticals

2003
Preserved myocardial [123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism: first case report.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5

    Topics: 3-Iodobenzylguanidine; Exons; Humans; Male; Middle Aged; Myocardium; Parkinsonian Disorders; Radionuclide Imaging; Radiopharmaceuticals

2005
Reduced 125I-meta-iodobenzylguanidine uptake and norepinephrine transporter density in the hearts of mice with MPTP-induced parkinsonism.
    Nuclear medicine and biology, 2006, Volume: 33, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3-Iodobenzylguanidine; Animals; Dose-Response Relationship, Drug; Heart; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Myocardium; Norepinephrine Plasma Membrane Transport Proteins; Parkinsonian Disorders; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution

2006
Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism.
    Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:11

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Case-Control Studies; Cerebrovascular Disorders; Female; Heart; Humans; Male; Middle Aged; Parkinsonian Disorders; Radionuclide Imaging; Radiopharmaceuticals

2006
Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2008, Volume: 23, Issue:1

    Topics: 3-Iodobenzylguanidine; Adult; Diagnosis, Differential; DNA Mutational Analysis; Female; Galvanic Skin Response; Genotype; Humans; Intracellular Signaling Peptides and Proteins; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Movement Disorders; Myocardium; Oncogene Proteins; Parkinson Disease; Parkinsonian Disorders; Point Mutation; Promoter Regions, Genetic; Protein Deglycase DJ-1; Protein Kinases; Protein Serine-Threonine Kinases; Radiopharmaceuticals; Severity of Illness Index; Surveys and Questionnaires; Tomography, Emission-Computed, Single-Photon; Ubiquitin-Protein Ligases

2008
Significant reduction of 125 I-meta-iodobenzylguanidine accumulation directly caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine, a toxic agent for inducing experimental Parkinson's disease.
    Nuclear medicine communications, 2002, Volume: 23, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3-Iodobenzylguanidine; Animals; Cells, Cultured; Desipramine; Dopamine Agents; Heart; Iodine Radioisotopes; Mice; Mice, Inbred C57BL; Myocardium; Neurons; Parkinsonian Disorders; PC12 Cells; Radionuclide Imaging; Rats

2002